thioguanine-anhydrous has been researched along with Carcinoma--Ehrlich-Tumor* in 14 studies
1 review(s) available for thioguanine-anhydrous and Carcinoma--Ehrlich-Tumor
Article | Year |
---|---|
BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Floxuridine; Fluorouracil; Folic Acid; Glutamine; Leukemia L1210; Mercaptopurine; Methotrexate; Mitomycin; Neoplasms; Neoplasms, Experimental; Pharmacology; Purines; Puromycin; Pyrimidines; Research; RNA; RNA, Neoplasm; Thioguanine; Thiouracil | 1963 |
13 other study(ies) available for thioguanine-anhydrous and Carcinoma--Ehrlich-Tumor
Article | Year |
---|---|
The influence of PLD repair on the induction frequency of 6-thioguanine resistant mutants in Ehrlich ascites tumour cells after exposure to X-rays and ultraviolet light.
We have studied the influence of conditions promoting repair or expression of potentially lethal damage (PLD) on the induction of 6-thioguanine resistant mutants in plateau phase Ehrlich ascites tumour cells after exposure to either X-rays or ultraviolet light (UV). The cells were assayed either immediately after irradiation, or after a 6-8 h incubation under plateau phase conditions (in the case of exposure to X-rays) or 24 h incubation in balanced salt solution (in the case of exposure to UV light) to allow repair of PLD. For expression of PLD the cells were incubated for 4 h with 120 microM beta-araA, a treatment known to result in an exponential survival curve. For selection of the induced mutants the cells were incubated with 1.5 micrograms ml-1 6-thioguanine after a growth period of 6-12 days in fresh medium to allow expression. The results indicated a decrease in the number of mutants induced per 10(5) cells, with both radiations, when these were allowed to repair PLD, as compared with that of cells processed immediately after irradiation. An increase in the number of mutants induced was observed after postirradiation treatment of X-irradiated cells with beta-araA, but a decrease after exposure to UV light and subsequent treatment with beta-araA. We suggest therefore that potentially lethal lesions resulting in the formation of the shoulder of the survival curve are not identical with the lesions causing the induction of mutants after exposure to X-rays, although both kinds of lesions could be subgroups of the same kind of initially induced lesions.(ABSTRACT TRUNCATED AT 250 WORDS) Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Cells, Cultured; Mice; Mutation; Thioguanine; Ultraviolet Rays; Vidarabine | 1984 |
Isolation of drug-resistant clones of Ehrlich ascites tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Clone Cells; Drug Resistance; Ethyl Methanesulfonate; Guanosine; Mutagens; Neoplasm Transplantation; Thioguanine | 1976 |
Manipulation of DNA synthesis in normal and neoplastic tissues with drugs.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carcinoma, Ehrlich Tumor; Cell Line; Cytarabine; Deoxyribonucleosides; DNA; DNA, Neoplasm; Female; Mice; Neoplasms, Experimental; Thioguanine; Time Factors; Vidarabine | 1974 |
Inhibitors of nucleoside and nucleotide metabolism.
Topics: Adenine; Adenine Nucleotides; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Erythrocytes; Guanine; Humans; Hypoxanthines; Mercaptopurine; Neoplasms; Nucleosides; Nucleotides; Pentosyltransferases; Phosphotransferases; Purines; Pyrimidines; Thioguanine | 1972 |
Studies on beta-D-xylofuranosyl-6-thioguanine in mice.
Topics: Adenine; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell Line; Chromatography; DNA, Neoplasm; Female; Furans; Glycine; Guanine; Immunosuppressive Agents; Male; Mice; Neoplasms, Experimental; Orotic Acid; Protein Biosynthesis; Purines; Pyrimidines; RNA, Neoplasm; Sulfur Isotopes; Thioguanine; Xylose | 1970 |
Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Drug Synergism; Injections, Intraperitoneal; Mercaptopurine; Mice; Neoplasms, Experimental; Nucleosides; Ribonucleosides; Ribonucleotides; Thioguanine; Time Factors | 1970 |
Relation between antitumor activity and chemical structure in some derivatives of 2-amino-6-purinethiol.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Female; Formamides; Injections, Intraperitoneal; Leukemia, Experimental; Mice; Organ Size; Sarcoma 180; Thioguanine; Time Factors | 1969 |
EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Ascites; Azaserine; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Fluorouracil; Leukemia L1210; Leukemia, Experimental; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Research; Thioguanine; Thiotepa; Toxicology | 1964 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; DNA; DNA, Neoplasm; Fluorouracil; Idoxuridine; Liver Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mercaptopurine; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nucleosides; Nucleotides; Purines; Research; RNA; RNA, Neoplasm; Sarcoma 180; Thioguanine; Uracil Mustard | 1963 |
METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.
Topics: Adenine; Adenine Nucleotides; Animals; Antineoplastic Agents; Azaserine; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Glycine; Metabolism; Mice; Nucleic Acids; Proteins; Purines; Research; RNA; RNA, Neoplasm; Thioguanine | 1963 |
The metabolism of 9-butyl-6-thioguanine in normal and neoplastic tissues.
Topics: Animals; Carcinoma, Ehrlich Tumor; Metabolism; Purines; Thioguanine | 1962 |
Treatment of ascites tumors with 4-aminopyrazolo (3,4-d)pyrimidine alone and in combination with azaserine, thioguanine, and 6-mercaptopurine.
Topics: Animals; Antineoplastic Agents; Ascites; Azaserine; Carcinoma, Ehrlich Tumor; Humans; Mercaptopurine; Neoplasms, Experimental; Pyrimidines; Thioguanine | 1961 |
Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
Topics: Animals; Ascites; Azaserine; Azoles; Carcinoma, Ehrlich Tumor; Humans; Mercaptopurine; Neoplasms; Neoplasms, Experimental; Pyrimidines; Serine; Thioguanine | 1960 |